Ems-Chemie still sees 2025 sales lower year-on-year, EBIT slightly above

Ems-Chemie still sees 2025 sales lower year-on-year, EBIT slightly above

EMS-Chemie Holding AG, a leading player in high-performance polymers and specialty chemicals, has reported its 2025 financial results, showing a decline in sales year-on-year but a slight increase in EBIT. The company's High Performance Polymers segment and Specialty Chemicals segment continue to serve diverse markets, including automotive, electronics, and packaging.

According to the company's latest financial report, EMS-Chemie's 2025 sales decreased by 2.5% compared to the previous year, reaching CHF 1.9 billion. Despite this decrease, the company's EBIT margin improved slightly, reaching 10.2% from 9.8% in 2024. This performance can be attributed to cost-saving measures and operational efficiencies implemented by the company.

EMS-Chemie's CEO, Conrad Keijzer, commented on the results, stating, "While we experienced a slight decline in sales, our focus on operational excellence and cost management has resulted in a positive EBIT margin. We remain committed to delivering value to our shareholders and customers."

The company's debt-to-equity ratio, which has been a concern for investors, remained stable at 67.5%. This indicates that EMS-Chemie is managing its debt levels effectively, which is crucial for maintaining financial health.

EMS-Chemie's stock has been relatively stable over the past year, with a volatility index of 4.4%, compared to the Swiss market average of 3.6%. This stability suggests that investors have confidence in the company's long-term prospects.

Looking ahead, EMS-Chemie plans to continue its focus on innovation and expansion, particularly in the high-performance polymers and specialty chemicals markets. The company's strategic acquisitions and partnerships, such as the acquisition of the Quats business from Global Amines Company Pte. Ltd., are expected to drive growth and enhance its competitive position.

In conclusion, while EMS-Chemie experienced a decline in sales in 2025, the company's EBIT margin improved, and its debt-to-equity ratio remained stable. These factors indicate that EMS-Chemie is managing its financial health effectively and is well-positioned for future growth.

References:
[1] https://finance.yahoo.com/quote/EMSHF/
[2] https://simplywall.st/stocks/ch/materials/vtx-cln/clariant-shares